2006
127. Goldsmith S, Elkayam U. A Dose-Ranging Pilot Study of Conivaptan in Acute Decompensated Heart Failure. Circulation,2006; 114:II_ 570
126. Goland S, Bitar F, Modi K, Akter MW, Janmohamed M, Hatamizadeh P, Elkayam U. Clinical Profile and Risk Predictors of Major Adverse Events in Patients with Peripartum Cardiomyopathy Circulation, 2006; 114: II_622.
2005
125. Modi K, Bitar F, Goland S, Jariatul K, Illum S, Akhter MW, Khan S, Raymundo B,Elkayam U: Left ventricular size and function at diagnosis the only predictor of failure to recover in peripartum cardiomyopathy. Circulation, 2005; 112: II_542
124. Tedoldi CL, Bordignon S, Caetano ME, Sebastiao AM, Clapauch SH, Uri Elkayam: Adverse outcomes in pregnant women with prosthetic heart valve: a risk analysis. Circulation, 2005; 112: II 716.
123. Elkayam U. Nesiritide May Diminish the Increased Acute Mortality Risk Associated with Worsening Renal Failure.
Circulation, 2005; 112: II_675.
122. Elkayam U, Ng TM, Mehra AO, Garty M: Magnitude of Effect and site of Action of Dopamine on the Renal Circulation in Patients with Severe Heart Failure. J Card Fail 2005; 11:6 (Suppl).
2004
121. O’Connor C, Adams K, Gattis W, Barbagelata A, Elkayam U, McGrew F, Ghali J, Benza R, Klapholz M, Ouyang J, Orlandi C, Gheorghiade M: Predictors of mortality in patients hospitalized with worsening heart failure: Insights from the ACTIV in CHF trial. J Am Coll Cardiol 2004;43 (Suppl. A): 181A.
2003
120. Elkayam U, Akhter M, Shotan A, Hameed A, Singh H, Khan S, Usman A, Khan M: Pregnancy Associated Cardiomyopathy: Clinical Profile in 137 Patients Diagnosed in the United States. J Am Coll Cardiol 2003; 41:6 (Suppl. A) 184A.
119. Elkayam U, Akhter M, Shotan A, Hameed A, Singh H, Khan S, Usman A, Khan M: Pregnancy-Associated Cardiomyopathy: Early Versus Late Presentation. J Am Coll Cardiol 2003; 41:6 (Suppl. A) 151A.
2002
118. Elkayam U: Renal insufficiency as a predictor of predictor of cardiovascular outcome in hospitalized patients with decompensated heart failure. J Am Coll Cardiol 2002; 39 (Suppl. A): 184A.
117. Elkayam U, Kim J, Currie AM, Margolis J: Prevalence of anemia and anemia treatment in patients with congestive heart failure. Presented at the American Heart Association 4th Scientific Forum on Quality of Care Outcome Research in Cardiovascular Disease and Stroke.
2001
116. Elkayam U, Prakash M, Subbiah S, Mehdi S, Nikitina A, Akhter W: Endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol. 2001; 38 Suppl 2: S47-8.
115. Elkayam U, on Behalf of the VMAC Study Group: The lack of ischemic cardiovascular adverse events with nesiritide (B-type natriuretic peptide) and nitroglycerin in the treatment of acute heart failure. J Cardiac Failure 2001; 7(Suppl 2): 59.
114. Elkayam U, on Behalf of the VMAC Study Group: Limitations of commonly used titrated doses of intravenous nitroglycerin in patients with acute decompensated heart failure. J Cardiac Failure 2001;7(Suppl 2): 12.
113. Canetti M, Lerman A, Karaalp IS, Akhter WM, Mehra S, Elkayam U: Abnormal Coronary blood flow Reserve in Idiopathic Dilated Cardiomyopathy is due to impairment of both Endothelium-Dependent and Independent Micorcirculotory Vasodilation. J Am Coll Cardiol 37 (Suppl. A): 187A, 2001.
2000
112. Burger AJ, Horton DP, Elkayam U, LeJemtel T, Ghali J: Evidence of Ventricular Ectopy at Baseline Is Not Predictive of the Proarrhythmic Effects of Dobutamine in the Treatment of Decompensated CHF: The PRECEDENT study. J Cardiac Failure 2000; 6:46.
111. Burger AJ, Horton DP, Elkayam U, LeJemtel T, Ghali JK: Comparison of the Effects of Dobutamine and Nesiritide ( B-Type Natriuretic Peptide) on Cardiac Ectopy in Acutely Decompensated Ischemic versus Non-Ischemic Cardiomyopathy. J Cardiac Failure 6:49, 2000.
110. Elkayam U, Silver MD, Burger AJ, Horton DP: The Effect of Short Term Therapy with Nesritide (B-Type Natriuretic Peptide) or Dobutamine on Long Term Survival. J Cardiac Failure 2000;6:44
1999
109. Burger AJ, Horton DP, Elkayam U, LeJemtel TH, Ghali J: Nesiritide is not associated with the proarrhythmic effects of dobutamine in the treatment of decompensated CHF: the PRECEDENT study. Circulation 1999; 100(18), I-647.
108. Tummala PP, Rao KS, Akhter MW, Karaalp IS, Hameed AB, Elkayam U: Peripartum cardiomyopathy: clinical profile of 100 patients diagnosed in the United States. Circulation 1999; 100:I-579.
107. Tummala PP, Akhter MW, Hameed AB, Karaalp IS, Rao KS, Johnson JV, Elkayam U: Risk of subsequent pregnancies in women with a history of peripartum cardiomyopathy. Circulation 1999; 100:I-381.
106. Hameed AB, Wani OR, Karaalp IS, Tummala PP, Canetti M, Goodwin M, Elkayam U: Valvular disease in pregnancy: effects on maternal and fetal outcome. Circulation 1999;100:I-148.
105. Elkayam U, Johnson JV, Shotana, Bokhauri S, Solodky A, Canetti M, Wani OR, Karaalp I S: Intermittent large dose nitrates added to standard therapy, improves left ventricular function and exercise capacity in patients with chronic heart failure. J Am Coll Cardiol 1999;33: 188A.
1998
104. Elkayam U, Neibam M, Haught H, Horton D: Safety study of nisiritide (human b-type natriuretic peptide) for the treatment of hospitalized patients with acutely decompensated CHF. J Cardiac Failure1998; 4:(Suppl. 1): 40.
103. Silver MA, Ghali JK, Horton D, Elkayam U: Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of acutely decompensated heart failure. J Cardiac Failure 1998; 4 (Suppl. 1): 40
102. Elkayam U, Mehra A, Kauffman JY, Gogia H, Bokhari S, Tummala PP: Attenuation of acetylcholine mediated coronary vasoconstriction with nonvasodilating dose of nitroglycerin in patients with heart failure: Evidence for nitroglycerin induced enhancement of endogenous nitric oxide effect? J Am Coll Cardiol 1998;31: 460A.
101. Elkayam U, Canetti M, Karaalp IS, Wani O, Gogia H, Kauffman J, Mehra A: Pulmonary circulatory response to endothelial stimulation in patients with chronic heart failure. J Am Coll Cardiol 1998;31: 432A.
1997
100. Mehra A, Cohen G, Johnson JV, Elkayam U: Effect of adenosine on the renal circulation in patients with chronic heart failure. J Am Coll Cardiol 1997;29 (Suppl. A): 370A.
1996
99. Elkayam U, Hurst A, Shotan A, Hoffman-Willey K, Johnson J, Koda R: Evidence for attenuated heart rate control with beta blockade in women with heart disease during pregnancy: A pharmacokinetic and pharmacodynamic study. J Am Coll Cardiol 1996;27(Suppl. A): 79A.
98. Elkayam U, Gadallah S, Mehra A, Vallabhaneni R, Johnson JV: Evaluation of magnitude of effect and site of action of dopamine on the renal circulation in patients with heart failure with the aid of intravascular ultrasound and Doppler techniques. J Am Coll Cardiol 1996; 27(Suppl. A): 338A.
1995
97. Ostrzega E, Elkayam U: Risk of Subsequent Pregnancy in Women with a History of Peripartum Cardiomyopathy: Results of a Survey. Circulation1995; 92 (Suppl. I): I-333.
96. Hurst AK, Shotan A, Hoffman-Willey K, Johnson J, Koda R, Goodwin TM, Elkayam U: Pharmacokinetics (PK) and heart rate control with atenolol during and after pregnancy. Pharmacotherapy 1995;15 (3): 364.
95. Hurst AK, Shotan A, Hoffman-Willey K, Goodwin TM, Johnson J, Koda R, Elkayam U: Heart rate control on beta adrenoreceptor blocking therapy during pregnancy in patients with cardiac disease. J Invest Med 1995;43 (Suppl. 2): 321A.
94. Elkayam U, Cohen G, Gogia H, Mehra A, Chandraratna PAN, Johnson JV: The effect of endothelial stimulation on the renal circulation in patients with chronic heart failure. J Am Coll Cardiol 1995; 25: 297A.
1994
93. Gogia H, Mehra A, Parikh S, Ajit-Uppal J, Johnson JV, Elkayam U: A randomized study to evaluate the effect of hydralazine on the development of nitrate tolerance in patients with heart failure. Circulation 90: I-601, 1994.
92. Elkayam U, Goodwin TM: Safety and efficacy of intravenous adenosine therapy for supraventricular tachycardia during pregnancy: Results of a national survey. J Am Coll Cardiol , 1994; 23:91A.
1993
91. Elkayam U, Shotan A, Mehra A, Ostrzega E: Calcium Channel Blockers in Heart Failure. J Am Coll Cardiol 1993; 22 (Suppl. A): 139A.
90. Mehra A, Shotan A, Kawanishi D, Ostrzega E, Vasquez-Johnson J, Elkayam U: Reduction in mitral valve regurgitant area secondary to left ventricular remodeling: A mechanism for improvement of mitral regurgitation mediated by vasodilator therapy. J Am Coll Cardiol 1993; 21 (Suppl. A): 352A.
89. Mehra A, Ostrzega E, Shotan A, Vasquez-Johnson J, Elkayam U: Overcoming early nitrate tolerance with escalating oral dose of isosorbide dinitrate in chronic heart failure. J Am Coll Cardiol 1993; 21 (Suppl. A): 252A.
1992
88. Ostrzega E, Mehra A, Widerhorn J, Shotan A, Johnson J, Rahimtoola SH, Elkayam U: Evidence for increased incidence of arrhythmias during pregnancy: A study of 104 pregnant women with symptoms of palpitations, dizziness or syncope. J Am Coll Cardiol 1992;19(3) (Suppl. A): 125A.
87. Widerhorn J, Riggio D, Bhandari AK, Rahimtoola SH, Elkayam U: Risk stratification of patients with nonischemic congestive cardiomyopathy and nonsustained ventricular tachycardia. Circulation 1992; 86: I-395.
86. Massie BM, Berk MR, Brozana S, Elkayam U, Plehn J, Kukim M, Murphy B, Neuberg G, Steingart R, DeHaan H for the FACET investigators: Can further benefit be achieved by adding a vasodilator to triple therapy in CHF: Results of the flosequinan-ACE inhibitor trial (FACET). Circulation 1992;86: I-645.
1991
85. Shotan A, Ostrzega E, Mehra A, Johnson J, Elkayam U: Reduction plasma cyclic guanosine monophosphate in patients with chronic heart failure and reduction following nitrate therapy. Circulation 1991;84(4): II-57.
84. Mehra A, Ostrzega E, Shotan A, Vasquez-Johnson J, Rahimtoola SH, Elkayam U: Potentiation of nitrate effect does occur after sulfhydryl groups supply in heart failure patients treated with isosorbide dinitrate. Circulation 1991; 84(4): II-57.
83. Mehra A, Ostrzega E, Shotan A, Vasquez-Johnson J, Rahimtoola SH, Elkayam U: Hemodynamic benefit of nitrate therapy in patients with heart failure already treated with angiotensin converting enzyme inhibition. J Am Coll Cardiol 1991;7: 163A.
82. Mehra A, Ostrzega E, Shotan A, Vasquez-Johnson J, Rahimtoola SH, Elkayam U: Overcoming early nitrate tolerance with escalating oral dose of isosorbide dinitrate in chronic heart failure. Clin Res 1991; 39: 121A.
81. Mehra A, Ostrzega E, Shotan A, Vasquez-Johnson J, Rahimtoola SH, Elkayam U: Beneficial effect of nitrate therapy in patients with heart failure already treated with captopril. Clin Res 1991; 39: 120A.
80. Mehra A, Ostrzega E, Widerhorn J, Shotan A, Vasquez-Johnson J, Rahimtoola SH, Elkayam U: Arrhythmias in pregnancy: prevalence and effect on fetal and maternal outcome in a large group of symptomatic women. Clin Res 1991; 39: 79A.
79. Mehra A, Ostrzega E, Shotan A, Vasquez-Johnson J, Rahimtoola SH, Elkayam U: Can captopril prevent nitrate tolerance in patients with heart failure? Clin Res 1991; 39:49A.
1990
78. Packer M, Narahara KA, Elkayam U, Sullivan JM, Pearly DL, Massie BM, Creager MA: Randomized, multicenter, double-blind, placebo-controlled study of the efficacy of flosequinan, a new, long-acting vasodilator drug, in patients with chronic heart failure. Circulation 1990; 82(Suppl III): 323.
1989
77. Elkayam U, Amin J, Mehra A, Vasquez J, Weber L, Jamison M, Rahimtoola SH: Effect of nifedipine, isosorbide dinitrate and their combination on exercise tolerance and clinical status in chronic heart failure. Circulation 1989; 80(Suppl II): 252,.
76. Elkayam U, Jamison M, Roth A, Kulick D, Vasquez J, Rahimtoola SH: Oral isosorbide dinitrate in chronic heart failure: tolerance development to QID vs TID regimen. J Am Coll Cardiol 1989; 13: 178A.
75. Elkayam U, Jamison M, Roth A, Kulick D, Vasquez J, Weber L, Rahimtoola SH: Hemodynamic tolerance to oral isosorbide dinitrate in chronic heart failure: should the drug be given every 6 hours? Clin Res 1989; 7: 93A.
1988
74. Jamison M, Widerhorn J, Weber J, Campese V, Elkayam U: Central and renal hemodynamic effects of a new agonist at peripheral dopamine and beta receptors (dopexamine) in heart failure. Circulation 1988; 78(Suppl II): 624.
73. Elkayam U, Roth A, Rahimtoola SH: Isometric exercise mediated hemodynamic worsening and its prevention with nitroglycerin in patients with chronic mitral regurgitation. J Am Coll Cardiol 1988; 11: 230A.
72. Kulick D, Bhandari A, Hong R, Petersen R, Elkayam U, Rahimtoola SH: Programmed ventricular stimulation in patients with dilated cardiomyopathy: effect of hemodynamic instability on indurability of ventricular arrhythmias. J Am Coll Cardiol 1988; 11: 72A.
71. Kotlewski A, McKay CR, Harrison EC, Kawanishi DT, Reid C, Chandraratna PAN, Bhandari A, Elkayam U, Niland J, Rahimtoola SH: Incremental value of clinical examination, echocardiography and cardiac catheterization in the evaluation of left ventricular dysfunction and pulmonary hypertension in valvular heart disease. J Am Coll Cardiol 1988; 11: 64A.
70. Kulick D, Hong R, Ryzen E, Rude R, Elkayam U, Rahimtoola SH, Bhandari A: Electrophysiologic effects of intravenous magnesium sulfate in patients with no apparent heart disease. Clin Res 1988; 35:110A.
69. Elkayam U, Roth A, Kulick D, McIntosh N, Weber L, Rahimtoola SH: A comparison between amrinone and nitroprusside: a clinical evidence for positive inotropic effect of amrinone in patients with severe heart failure. Clin Res 1988; 5: 106A.
1987
68. Elkayam U, Kulick D, Roth A, McIntosh N, Weber L, Rahimtoola SH: Early tolerance to oral nitrate therapy in patients with chronic heart failure: effect of dosing intervals. Circulation 1987; 76(Suppl IV): 256.
67. Kulick D, Roth A, McIntosh N, Elkayam U: Resistance to isosorbide dinitrate in patients with chronic heart failure: incidence and attempt at hemodynamic prediction. Circulation 1987; 76(Suppl IV): 177.
66. Roth A, Rahimtoola S, Elkayam U: Enhancement of hemodynamic effects of hydralazine with nitroglycerin in patients with chronic mitral regurgitation. Circulation 1987; 76(Suppl IV): 89.
65. Kotlewski A, McKay CR, Harrison EC, Kawanishi DT, Reid CL, Chandraratna PAN, Bhandari A, Elkayam U, Niland J, Rahimtoola SH: Incremental value of clinical examination echocardiography and cardiac catheterization in the evaluation of mitral valve disease. Circulation 1987; 76(Suppl IV): 88,.
64. Roth A, Campese VM, Hsueh W, McIntosh N, Rahimtoola SH, Elkayam U: Failure of intravenous amrinone to improve renal hemodynamics and neurohumoral status in patients with severe chronic heart failure. J Am Coll Cardiol 1987; 9: 103A.
63. Elkayam U, Kulick D, McIntosh N, Roth A, Rahimtoola SH: Incidence of early tolerance to continuous intravenous nitroglycerin infusion in patients with coronary artery disease and heart failure. J Am Coll Cardiol 1987; 9: 103A.
62. Elkayam U, Roth A, Weber L, Rahimtoola SH: Nitrate Resistance: Failure of intravenous nitrate to reduce elevated left ventricular filling pressure in acute myocardial infarction, a common and unpredictable phenomenon. J Am Coll Cardiol 1987; 9: 23A.
61. Roth A, Campese VM, Hsueh W, McIntosh N, Rahimtoola SH, Elkayam U: Effects of intravenous amrinone on renal hemodynamics and neurohumoral status in patients with severe chronic heart failure. Clin Res 1987; 35: 113A.
60. Kulick D, Roth A, McIntosh N, Rahimtoola SH, Elkayam U: Resistance to isosorbide dinitrate in patients with chronic heart failure: incidence and attempt at hemodynamic prediction. Clin Res 1987; 35: 109A.
59. Kulick D, McIntosh N, Hsueh W, Campese V, Rahimtoola SH, Elkayam U: Diltiazem in patients with severe left ventricular systolic dysfunction: evaluation of central and renal hemodynamic response. Clin Res 1987;35: 108A.
58. Elkayam U, Roth A, Kumar A, Kulick D, McKay CR, Rahimtoola SH: Hemodynamic and volumetric effects of nitroglycerin in chronic severe mitral regurgitation. Clin Res 1987; 35: 103A.
1986
57. Roth A, Freidenberger L, Baruch T, Rahimtoola SH, Elkayam U: Hemodynamic effects of nitrate therapy during isometric exercise in patients with chronic heart failure. J Am Coll Cardiol 1986; 7: 233A.
56. Roth A, Kumar A, Kulick D, McKay CR, Kawanishi D, Rahimtoola SH, Elkayam U: Beneficial effects of nitrate therapy on left ventricular hemodynamics and function in patients with chronic severe mitral regurgitation. J Am Coll Cardiol 1986; 7: 170A.
55. Roth A, Harrison E, Mitani G, Freidenberger C, Rahimtoola SH, Elkayam U: Diltiazem vs digoxin for heart rate control in patients with chronic atrial fibrillation. J Am Coll Cardiol 1986; 7: 69A.
54. Roth A, Kulick D, Fredenberger L, Hong R, Rahimtoola SH, Elkayam U: Early tolerance to hemodynamic effects of sustained nitrate therapy with high-dose Transdermal nitroglycerin in patients with severe chronic heart failure. J Am Coll Cardiol 1986; 7: 27A.
53. Roth A, Henriquez B, Weber L, Freidenberger L, Rahimtoola SH, Elkayam U: Intravenous isosorbide dinitrate in acute myocardial infarction and pump failure: investigation of dose requirement, magnitude and persistence of effects and hemodynamic rebound. Clin Res 1986; 34: 13A.
52. McKay CR, Nanna M, Reid CL, Kawanishi D, Stiles Q, Elkayam U, Rahimtoola SH: Superiority of aortic valve replacement over arteriolar dilator therapy for symptomatic chronic severe aortic regurgitation. Clin Res 1986; 4: 12A.
51. Au P, McKay CR, Kotlewski D, Elkayam U, Tonnemacher D, Weiss J, Reid CL, Chandraratna PAN, Rahimtoola SH: Error of thermodilution cardiac output measurements in severe tricuspid regurgitation. Clin Res 1986; 34: 3A.
1985
50. Elkayam U, Roth A, Weber L, Kawanishi D, McKay CR, Rahimtoola SH: The effect of nifedipine on cardiac hemodynamics and performance in patients with chest pain already treated with propranolol. Chest 1985; 88: 355.
49. Elkayam U, Weber L, Roth A, Hsueh W, Rahimtoola SH: Isometric exercise in severe chronic heart failure: hemodynamic and hormonal response and effect of arterial dilation with hydralazine. J Am Coll Cardiol 1985; 5: 460.
48. Elkayam U, Parikh K, Torkan B, Weber L, Cohen JL, Rahimtoola SH: Absence of Effect of diltiazem on digoxin serum concentration and renal clearance in patients with cardiac disease. J Am Coll Cardiol 1985; 5: 419.
47. Elkayam U, Roth A, Hsueh W, Weber L, Freidenberger L, Rahimtoola SH: Neurohumoral changes following arterial dilation with hydralazine and nifedipine in heart failure. Clin Res 1985; 33: 88A.
46. Elkayam U, Parikh K, Torkan B, Weber L, Cohen JL, Rahimtoola SH: Lack of interaction between diltiazem and digoxin in patients with heart disease. Clin Res 1985; 33: 88A.
1984
45. Elkayam U, Henriquez B, Weber L, Tonnemacher D, Rahimtoola SH: Lack of hemodynamic effect of high dose transdermal nitroglycerin in severe heart failure. Circulation 1984; 70: 454.
44. Kawanishi D, McKay CR, Chandraratna PAN, Nanna M, Reid CL, Elkayam U, Siegel M, Rahimtoola SH: Cardiovascular response to dynamic exercise in symptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1984; 3: 534.
43. Elkayam U, Weber L, Campese V, Massey S, Rahimtoola SH: Acute effect of arterial vasodilation with nifedipine on renal hemodynamics in patients with severe chronic heart failure. J Am Coll Cardiol 1984; 3: 479.
42. Elkayam U, Weber L, McKay CR, Rahimtoola SH: Variable, unpredictable and deleterious hemodynamic response to oral nifedipine in severe chronic heart failure: an experience in 32 patients. J Am Coll Cardiol 1984; 3: 478.
1983
41. Rose J, Chandraratna PAN, McKay CR, Elkayam U, Nanna M, Nimalasuriya A, Rahimtoola SH: Accuracy of determination of changes in cardiac output by transcutaneous continuous wave ultrasound Doppler computer. Circulation 1983; 68(Suppl III): 367.
40. Elkayam U, Weber L, Rose J, McKay CR, Rahimtoola SH: Nifedipine vs hydralazine in the treatment of severe heart failure: an evidence for a negative inotropic effect of nifedipine. Circulation 1983; 68(Suppl III): 8.
39. McKay CR, Nanna M, Kawanishi D, Elkayam U, Rahimtoola SH: Hydralazine dose determines duration of effect in chronic aortic regurgitation. Circulation 1983; 68(Suppl III):340.
38. McKay CR, Nanna M, Elkayam U, Kawanishi D, Chandraratna PAN, Rahimtoola SH: Long-term vasodilator treatment of chronic aortic regurgitation, preliminary evidence of hemodynamic and functional improvement. Circulation 1983; 68(Suppl III): 300.
37. Elkayam U, McKay CR, Weber L, Torkan B, Eisenberg D, Berman D, Rahimtoola SH: The effects of hydralazine on hemodynamic response to isometric exercise in patients with chronic aortic insufficiency. Clin Pharm Therap 1983; 33: 204.
36. Elkayam U, Weber L, Torkan B, Rahimtoola SH: Hemodynamic effects of nifedipine in chronic heart failure. Clin Pharm Therap 1983; 33: 204.
35. Elkayam U, Weber L, Torkan B, Berman D, Rahimtoola SH: Hemodynamic effects of nifedipine in patients with severe chronic congestive heart failure. Clin Res 1983; 31: 19A.
34. McKay CR, Nanna M, Kawanishi D, Elkayam U, Rahimtoola SH: Duration of hemodynamic effects of hydralazine in chronic aortic regurgitation: a function of dose. Clin Res 1983; 31:14A.
33. Kawanishi D, McKay CR, Chandraratna PAN, Nanna M, Elkayam U, Reid C, Siegel M, Rahimtoola SH: Circulatory response to exercise in patients with chronic aortic regurgitation: a decrease in aortic regurgitation. Clin Res 1983; 31:11A.
32. Gardin JM, Tobis JM, Dabestani A, Smith C, Elkayam U, Castlemen E, Allfie A, Henry WL: Superiority of two-dimensional measurement of aortic vessel diameter in Doppler echocardiographic estimates of left ventricular stroke volume. Clin Res 1983; 31:8A.
31. Elkayam U, Weber L, Torkan B, Berman D, Rahimtoola SH: Intravenous nitroprusside is superior to oral nifedipine in the acute treatment of patients with severe congestive heart failure. Clin Res 1983; 31:7A.
30. Elkayam U, McKay C, Weber L, Torkan B, Eisenberg D, Berman D, Rahimtoola SH: Beneficial effects of oral hydralazine on hemodynamic response to isometric exercise in patients with chronic aortic insufficiency. Clin Res 1983; 31:6A.
1982
29. Tobis J, Nalcioglu O, Seibert JA, Roeck WW, Iseri LT, Elkayam U, Johnston W, Henry WL: Digital intravenous angiography: a new technique for obtaining ventriculograms following intravenous injection of iodinated contrast material. Am J Cardiol 1982; 49:985.
28. Elkayam U, Gardin JM, Berkley R, Hughes CA, Henry WL: Use of Doppler blood flow velocity measurements to evaluate the response of systemic vascular resistance to vasodilators in patients with congestive heart failure. Am J Cardiol 1982; 9:943.
27. Johnston WD, Tobis J, Nalcioglu O, Seibert A, Roeck WW, Iseri LT, Elkayam U, Henry WL: End-diastolic mask subtraction: an improved method for displaying wall motion abnormalities using a digital angiography computer system. Am J Cardiol 1982; 49:935.
26. Tobis J, Nalcioglu O, Seibert A, Roeck W, Iseri L, Elkayam U, Johnston W, Henry W: Digital intravenous angiography: a new technique for obtaining ventriculogram following intravenous injection of iodinated contrast material. Clin Res 1982; 30:22A.
25. Elkayam U, Gardin JM, Berkley R, Hughes CA, Henry WL: The use of Doppler flow velocity measurement to assess vasodilator induced changes in stroke volume and systemic vascular resistance. Clin Res 1982; 30:7A.
1981
24. Tobis JM, Nalcioglu O, Seibert JA, Roeck WW, Iseri LT, Elkayam U, Johnston WD, Henry WL: Use of digital angiography in assessment of ventricular ejection fraction and pacing induced wall motion abnormalities. Circulation 1981; 64(Suppl IV):250.
23. Elkayam U, Wilson A, Morrison J, Davis J, Klosterman P, Salness K, Louvier J, Henry WL: A non-invasive assessment of cardiac output by a single breath technique. Circulation 1981; 64(Suppl IV):300.
22. Elkayam U, Gardin J, Berkley R, Hughes C, Henry WL: The value of aortic flow measurements using Doppler technique for the quantitative assessment of changes in stroke volume. Circulation 1981; 64(Suppl IV):256.
21. Tobis J, Iseri L, Elkayam U, Udall J, Gardin J, Henry W: Angulated coronary angiogram in the long axis view. Clin Res 1981; 29:246A.
20. Elkayam U, Wilson A, Davis J, Klosterman P, Louvier J, Morrison J, Henry WL: An evaluation of a new single breath technique for a non-invasive assessment of cardiac output. Clin Res 1981; 29:445A.
19. Elkayam U, Mumford M, Tobis J, Henry W: Thermodilution cardiac output determination: the effect of injectates volume and temperature on accuracy and reproducibility. Clin Res 1981; 29:188A.
1980
18. Gardin JM, Iseri LT, Elkayam U, Tobis J, Childs W, Burn CS, Henry WL: Use of Doppler echocardiography in the non-invasive assessment of left ventricular dysfunction in patients with dilated cardiomyopathy. Circulation 1980; 62:III-200.
17. Freeman M, Berman D, Maddahi J, Staniloff H, Elkayam U, Pantaleo N, Waxman A, Forrester J, Swan HJC: Comparison of upright and supine exercise of scintigraphic ventriculography in patients with suspected coronary artery disease. Clin Res 1980; 28:170A.
16. Berman D, Pantaleo N, Elkayam U, Freeman M, Staniloff H, Maddahi J, Garcia E, Waxman A, Forrester J, Swan HJC: Scintigraphic assessment of latent mechanical function: comparison of regional and global ventricular responses immediately after upright exercise following nitroglycerin. Clin Res 1980; 28:157A.
15. Staniloff HM, Diamond G, Berman DS, Freeman MR, Elkayam U, Waxman A, Forrester JS: An integrated format for multiple testing in coronary artery disease. Am J Cardiol 1980; 45:463.
1979
14. Maddahi J, Berman D, Freeman M, Elkayam U, Staniloff H, Pantaleo N, Forrester J, Swan HJC, Waxman A: Simultaneous assessment of right and left ventricular responses to exercise using multiple gated equilibrium scintigraphy: increased accuracy for evaluation of the extent of coronary artery disease. J Nuclear Med 1979; 20:625.
13. Staniloff H, Diamond G, Hirsch H, Berman D, Charuzi Y, Freeman M, Elkayam U, Vas R, Waxman A, Forrester J: Sequential bayesian analysis of multiple non-invasive tests for the accurate detection of coronary artery disease. J Nuclear Med 1979; 20:651.
12. Elkayam U, Mathur M, LeJemtel T, Frishman W, Strom J, Sonnenblick EH: Comparative hemodynamic effects of oral prazosine and hydralazine in refractory heart failure. Clin Res 1979; 27:163A.
11. Freeman M, Pichler M, Berman D, Shah PK, Maddahi J, Waxman A, Staniloff H, Elkayam U, Anderson A, Swan HJC: Improved non-invasive assessment of segmental wall motion in acute myocardial infarction by an additional 70 degree LAO view in multiple gated equilibrium scintigraphy. Clin Res 1979; 27:3A.
10. Staniloff H, Berman D, Elkayam U, Freeman M, Diamond G, Waxman A, Drake D, Forrester J: Equilibrium nuclear probe for the measurement of left ventricular ejection fraction: detailed analysis of effects of mode of acquisition and observer variation. Clin Res 1979; 27:12A.
9. Elkayam U, Berman D, Maddahi J, Diamond G, Charuzi Y, Waxman A, Stanilof H, Freeman M, Vas R, Forrester J: Combination of exercise TL-201 myocardial scintigraphy and TC-99M RBC wall motion study: a useful noninvasive predictor of extent and location of coronary arterial disease. Clin Res 1979; 27:3A.
8. Elkayam U, LeJemtel T, Mathur M, Ribner H, Frishman W, Strom J, Sonnenblick EH: Marked early attenuation of hemodynamic effect of oral prazosin therapy in chronic congestive heart failure. Am J Cardiol 1979; 43:403.
7. Frishman W, Strom J, Davis R, Elkayam U, Weinstein J, Sonnenblick EH: Efficacy of a new beta-adrenergic blocking agent (pindolol) in the acute and chronic therapy of supraventricular arrhythmias. Am J Cardiol 1979; 43:431.
6. Ribner H, LeJemtel T, Elkayam U, Weinstein J, Sonnenblick EH: Relationship between initial systemic vascular resistance and the response to vasodilators in severe chronic congestive heart failure. Am J Cardiol 1979; 43:404.
1987
5. Becker RM, Strom J, Elkayam U, Frishman W, Frater RWM, Sonnenblick EH: Effects of hypothermic hyperkalemic cardioplegic arrest of ventricular performance during cardiac surgery assessment by intraoperative echocardiography. Ann Royal Coll Phys Surg, Canada 1978; 11:32.
4. Frishman W, Strom J, Elkayam U, LeJemtel T: LB-46 therapy in supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospastic disease. Bulletin NY Acad Med 1978; 54:315.
1977
3. Strom J, Frishman W, Elkayam U, LeJemtel T, Ribner H, Strobeck J, Stein J, Sonnenblick EH: Pre- and post-exercise echocardiography in evaluating ischemic ECG changes in patients without chest pain. Circulation 1977; 56(Suppl III):198.
2. Frishman W, Stampfer M, Strom J, Elkayam U, LeJemtel T, Weinstein J, Sonnenblick EH: Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm. Circulation 1977; 56(Suppl III):198.
1. LeJemtel T, Hellman C, Elkayam U, Strom J, Blaufox D, Frishman W, Ribner H, Sonnenblick EH: Hemodynamics and renal response to oral hydralazine therapy in severe heart failure. Circulation 56(Suppl III):9, 1977.
90033. Ph:323 226 7541USC Cardiovascular Medicine, 1200 North State Street, Room 7621, LA, CA 90033. Ph:323 226
